Sign in
4

Changes in Ownership

ProQR Therapeutics N.V. Filed Acc 0001104659-26-081762

Chief Executive Officer bought 150,000 shares at $1.59 ($238,500)

From the SEC's structured data for this filing

Trades in this filing

de Boer Daniel Anton · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-07-07 Purchase : show line 1 in the form +150,000 $1.59 $238,500 150,000 D
Open-market purchases · 150,000 sh · avg $1.59 · $238,500
Loading xslF345X06/tm2620064-1_4seq1.xml…